TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.

Denise A YardleyEdward R ArrowsmithBrooke R DanielJanice EakleAdam BrufskyDavid R DrosickFred KudrikLinda D BossermanMark R KeatonSharon A GobleJeffrey A BubisVictor M PriegoKelly PendergrassYvonne ManaloMartin BuryDonald S GravenorGladys I RodriguezRoger C InhornRobyn R YoungWilliam N HarwinCaryn SilverJohn D HainsworthHoward A Burris

Published in: Breast cancer research and treatment (2017)

Clinical Trials.gov Identifier, NCT00789581.

Keyphrases

phase iii
clinical trial
early stage
open label
phase ii
double blind
drug delivery
low dose
high dose
placebo controlled
lymph node
neoadjuvant chemotherapy